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ABSTRACT 
Porcine epidemic diarrhea virus (PEDV) has been an important pathogen in Europe and 
Asia for several decades. It was identified in the United States (U.S.) swine population for the 
first time in April 2013, and spread rapidly across country and into Canada and Mexico.  
However, no information has been published regarding the minimum infectious dose (MID) of 
PEDV in different pig models. The main objective of this study was to determine the oral 
minimum infectious dose of PEDV in naïve conventional neonatal piglets and weaned pigs. A 
U.S. virulent PEDV prototype isolate (USA/IA19338/2013) with known infectious titer was 
serially ten-fold diluted in virus-negative cell culture medium, and inoculated into 5-day-old and 
3-week-old pigs. Our data showed that PEDV is infectious in an age-dependent manner with a 
significantly lower MID for neonatal pigs compared to weaned pigs.  Furthermore, it showed 
that, once an infection was established in pigs, the initial dose of PEDV administered did not 
affect the extent of fecal viral shedding, severity of histopathologic lesions, or magnitude of 
antibody titer subsequently developed.  This information should be taken into consideration 
when interpreting clinical relevance of PEDV PCR results, designing a PEDV bioassay model, 
as well as emphasizes the importance of strict biosecurity and thorough cleaning/disinfection on 
sow farms. 
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CHAPTER 1: INTRODUCTION 
Background 
 Porcine epidemic diarrhea virus (PEDV) is the causative agent for Porcine epidemic 
diarrhea (PED), a disease which was first described in England in the 1970’s.  It subsequently 
spread through much of Europe and Asia, before being introduced to the United States in April 
of 2013.  Within one year of introduction to the US, the virus had been detected in 29 states and 
resulted in the death of over 7 million pigs.  Factors that contribute to the ease of introduction 
and spread of a virus through a population include the immune status of the host population, the 
inherent ability of the virus to resist environmental degradation, and the dose of virus necessary 
to infect an individual animal.  Practical investigation into these factors should be framed in the 
context of relevant diagnostic assays.  Doing so allows for better application of scientific data to 
real life clinical scenarios. 
Objectives 
The objectives of this research were to: 1. Correlate PEDV RT-PCR Ct values to 
infectious titers of the virus. 2. Determine the minimum infectious dose of PEDV in naïve 
neonatal piglets.  3. Determine the infectious dose of PEDV in naïve weaned pigs and to assess 
their corresponding antibody responses. 
Thesis Organization 
 This thesis consists of an introduction, literature review, one original research chapter 
that has been published in PLOS ONE, and a conclusion.  Chapter 1 serves as the introduction 
and chapter 2 serves as the literature review.  Topics included in the literature include PEDV 
classification and genome organization, genetic diversity and molecular epidemiology, 
transmission, infection and pathogenesis, immune response, diagnosis of infection, and 
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prevention and control.  Chapter 3 consists of original research regarding the effects of PEDV 
infectious doses on outcome of infection in neonatal and weaned pigs.  The author’s role in this 
study included development of study design, titration of the viral isolate, execution of animal 
studies, necropsy and sample collection from test subjects, execution of laboratory testing, 
analysis and interpretation of results, and manuscript writing.  This chapter is presented as it 
appears in publication.  Chapter 4 consists of a discussion/conclusion. 
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CHAPTER 2: LITERATURE REVIEW 
 
Classification and Genome Organization 
Taxonomy 
Porcine epidemic diarrhea virus (PEDV) is a spherical, enveloped, positive sense and 
single stranded RNA virus.  It is a member of the genus Alphacoronavirus along with two other 
important swine pathogens: transmissible gastroenteritis virus (TGEV) and porcine respiratory 
coronavirus (PRCoV), as well as numerous other mammalian coronaviruses.  This genus along 
with the 3 others: Betacoronavirus, Gammacoronavirus, and Deltacoronavirus make up the 
subfamily Coronavirinae.  Coronavirinae together with Torovirinae make up the Coronaviridae 
family, so named because of member viruses’ crown-like appearance on electron microscopy.  
Members of this family along with the members of 3 other families: Arteriviridae, Roniviridae, 
and Mesonivirinae comprise the relatively newly described order Nidovirales (1).  Membership 
to this order is based on genomic organization, replication/transcription strategy, and 
characteristics of the replicase/transcriptase polyprotein (2).  It derives its name from the Latin 
word nido meaning “nest” due to the fact that members of this order replicate via transcription of 
a set of nested subgenomic messenger RNA’s at the 3’end of their genome.  Porcine reproductive 
and respiratory syndrome virus (PRRSV), perhaps the most economically important swine 
pathogen in the US, is a member of the Arteriviridae family.  This means that 2 of the most 
devastating swine diseases in the United States (PRRS and PED) are caused by Nidoviruses. 
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Genome Structure and Protein Function 
The genome of PEDV is approximately 28 KB in length, and is encompassed by a 5’ 
cap and 3’ polyadenylated tail.  It encodes both 5’ and 3’ untranslated regions along with 7 open 
reading frames (ORFs): 1a, 1b, and 2-6 (3, 4).  
ORFs 1a and 1b comprise the 5’ two-thirds of PEDV’s genome and encode what is 
known as the “replicase” gene.  Expression of this gene is made possible by a “-1 ribosomal 
frameshift” occurring during some constant proportion of translation events.   This frame shift 
occurs due to the presence of a “slippery sequence”, 5’-UUUAAAC-3’, and a downstream RNA 
pseudoknot structure, which together result in a change in “reading frame” and no termination at 
the ORF 1a stop codon (5).  The end result of this translation strategy is production of a 
polyprotein 1a (pp1a) most of the time, and production of the longer polyprotein 1ab (pp1ab) 
some smaller proportion of the time.  Proposed reasons for this mechanism include production of 
the non-structural proteins (nsps) encoded by ORFs 1a and1b at a constant proportion necessary 
for assemblage into the replicase-transcriptase complex (RTC) (6), and/or to delay the 
production of the enzymatic nsps processed from pp1ab until those processed from pp1a have 
altered the cellular environment to better allow for RNA synthesis (7). 
These two polyproteins are post translationally processed to form 16 non-structural 
proteins (nsp1-16), with cleavage of pp1a forming nsp1-11, and cleavage of pp1ab forming 
nsp1-10, and nsp12-16.  These proteolytic products then assemble to form the replication 
transcription complex (RTC).  While the function of the individual nsps has not been extensively 
studied in PEDV specifically, they have been described for others in the coronavirus family.  
Nsp1 has been demonstrated to aide in evasion of the host immune system through inhibition of 
Type 1 IFN production (8).   The large nsp3 protein has been shown to have a variety of 
5 
 
functions, including: autoprotolytic cleavage of nsp1, nsp2, and nsp3 from pp1a and pp1ab via 
“papain like proteases” contained within nsp3 (9), interaction with the N protein to help initiate 
RNA synthesis (10), several mechanisms to aid in avoiding host immunity (11, 12), as well as 
others not listed here.  Nsp4, nsp6, and nsp3 contain transmembrane helices that bind the RTC to 
cellular membranes (13, 14).  Nsp5 also referred to as the main protease (Mpro) or 3C-like 
protease (3CLpro) is responsible for the 11 cleavages of pp1a/pp1ab not performed by nsp3 (15, 
16).  Nsp7 and nsp8 form a structure with a central pore that has been proposed as the RNA 
clamp for the RNA Dependent RNA Polymerase encoded by nsp12 (17, 18).  Nsp9 binds single 
stranded RNA (ssRNA), while nsp10 binds zinc and may also play a role in the processing of 
nsp5 (16, 19-22).  Nsp13, nsp14, and nsp16 are involved in the production of the 5’-termainal 
cap found on the viral genome and sgRNA (16, 23-26).  Finally, both nsp14 and nsp15 serve as 
ribonucleases, with nsp14 apparently playing a role in the “proof reading” of viral RNA during 
replication (16, 27-29). 
Expression of ORFs 2-6 is accomplished via the production of corresponding sgRNAs.  
Cis-acting elements at the 5’ and 3’ end of the genome interact during replication allowing for 
discontinuous extension of the replicating RNA strand, leading to the synthesis of sgRNA via 
negative stranded RNA intermediates.  Each sgRNA subsequently serves as a template for the 
protein encoded by the ORF at its 5’ end (5). 
ORF2 encodes a class 1 fusion protein called the spike protein (S protein).  This 128-160 
kilodalton (kDa) S protein monomer consists of a highly variable S1 domain, and highly 
conserved S2 domain (30-32).  These monomers trimerize to form the 18-23nm club like 
projections seen on electron micrographs of coronaviruses, with the S1 and S2 domains forming 
the bulbous and stalk like portions of this structure respectively (33).  Glycosylation of the S 
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monomers occurs cotranslationally, as well as after the S trimer is formed (33).  The S1 portion 
contains the receptor binding domain (RBD), which binds to porcine aminopeptidase N (pAPN) 
found on host enterocytes (34).  This allows for entry into the host cell, although the exact 
mechanism of entry varies among coronaviruses and has not yet been described for PEDV.  
Additionally, the S protein is postulated to harbor neutralization epitopes and is also associated 
with viral virulence/attenuation (35-39). 
The accessory protein encoded by ORF3 may be associated with cell culture adaptation 
and may also have an influence on cell cycle and subcellular structure (40, 41). 
ORF4 encodes the 8-12 kDa envelope protein (E protein).  This small unglycosylated 
protein appears to interact with the membrane protein (M protein) during envelope formation 
(42).  The E protein also appears to play a role in virion release (43). 
ORF5 encodes the M protein.  This 25-30 kDa protein contains a large globular 
endodomain, 3 transmembrane domains, and a small extensively glycosylated ectodomain (44).  
It is the most abundant structural protein found in coronaviruses, and appears to be responsible 
for their spherical shape as well as contact with their nucleocapsid (45, 46). 
The 43-50 kDa nucleocapsid protein (N protein) is encoded by ORF6.  This protein binds 
to viral RNA, forming the protein component of the helical nucleocapsid (5, 7).  It also binds the 
globular endodomain of the M protein (47, 48).  The N protein has also been shown to 
antagonize interferon-β production (49). 
 
Genetic Diversity and Molecular Epidemiology of PEDV 
Phylogenetic analysis of global PEDV isolates has been performed based on full length 
genome, full length S gene, S1, S2, E, M, N, and ORF 3 gene nucleotide sequences.  Of these 
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analyses, those based on full length S, S1, and S2 most closely resembled the genetic diversity 
seen with whole genome analysis, demonstrating their utility as targets for studying genetic 
relatedness of PEDV isolates (50).  PEDV isolates can be phylogenetically separated into 2 
genogroups: G1 and G2 based on variations in the N-terminal domain of the S protein (51).  
These can be further separated into subgroups G1a, G1b, G2a, and G2b.  CV777 the prototype 
PEDV isolate, first described in Europe in 1978, belongs to G1a (32) .  The first Asian country 
that reported a PEDV outbreak was Japan in 1982 (52).  Since then PEDV epidemics have been 
described in many Asian countries including China, South Korea, Thailand, and Vietnam (53-
59).  Many PEDV isolates responsible for the PEDV epidemics in Asia have a specific set of 
small insertions and deletions within the S protein when compared to CV777, placing them in G2 
(60).  Since October 2010, a large-scale and severe PED epizootic had occurred in multiple 
provinces in China, characterized by high mortality rates among suckling piglets (61, 62). 
PEDV was detected in US swine for the first time in April 2013 with severe clinical 
presentations (63) and the virus spread rapidly across the country, resulting in the estimated 
death of over 7 million pigs in the first year and substantial economic losses (64).  Isolates 
initially identified in the 2013 US outbreak,  termed “US PEDV prototype strains,” were most 
genetically similar (>99.5% nucleotide identity) to the Chinese isolate AH2012 (50, 51, 65).  
Subsequent to initial US PEDV outbreak, US prototype-like PEDV has been identified in 
Canada, Mexico, Taiwan, South Korea, and Japan (66-70).  
In the spring of 2014 a new so called “variant” strain of PEDV (OH851) was identified in  
US swine with mild clinical signs based on field observations (71).  When compared to the US 
PEDV prototype strains, the US PEDV variant strain has 3 deletions (a 1-nt deletion at position 
167, a 11-nt deletion at positions 176-186, and a 3-nt deletion at positions 416-418) and one 6-nt 
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insertion between positions 474 and 475 in the spike gene; thus this variant strain was also called 
S INDEL strain (67).  However, some people have argued with calling the US PEDV variants as 
‘S INDEL’ strain because they think genetic comparisons of all PEDV strains should be made to 
the global prototype strain CV777 (32).  But since a number of publications have used ‘S 
INDEL’ to describe the US PEDV variants (67, 72, 73), in order not to create further confusions, 
we have proposed to refer US PEDVs as ‘US PEDV prototype strain’ and ‘US PEDV S-INDEL-
variant strain’ (65, 74).    Phylogenetic analysis based on the first 1170 nucleotides of the S1 
region indicated that the US PEDV S-INDEL-variant strain was most closely related to the 
Chinese G1b isolate CH/HBQX/10 (71).  It is likely that G1b strains arose from recombination 
events between G1a and G2 strains in China in or before 2010 (32, 61).   Retrospective testing 
demonstrated that the US PEDV prototype strain was present in the US from April 15, 2013 and 
the US PEDV S-INDEL-variant strain was present in the US from May 16, 2013 (Chen et al, 
unpublished data).  Two PEDV strains were likely introduced into the US concurrently.  
Interestingly, US S-INDEL-variant-like PEDVs have also been detected in South Korea, Japan, 
Germany, Belgium, France, Portugal, Austria and Slovenia (75-82).    
 
Transmission of PEDV 
Transmission of PEDV, as with most enteric pathogens, occurs primarily via a fecal-oral 
route.  Aerosol transmission has been described for other alphacoronaviruses in pigs and may 
represent a potential transmission route for PEDV as well (83).  The geographical spread of 
PEDV from infected premises has been demonstrated to mirror prevailing wind patterns, 
suggesting airborne dissemination of the virus (84).  Alonso et al. detected airborne PEDV RNA 
within positive premises and as far as 10 km downwind from those same sites.  While they were 
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able to demonstrate the infectivity of airborne PEDV RNA within a positive premise (via oral 
gavage into a 10 day old pig bioassay), they were not able to demonstrate infectivity of PEDV 
RNA collected downwind from those sites (85).  It is important to note that while this 
demonstrates that PEDV is able to remain infectious while aerosolized, it does not demonstrate 
the ability of aerosolized PEDV to remain infectious when exposed to environmental factors 
such as heat and UV radiation.  Furthermore, it does not conclusively demonstrate aerosol 
transmission within a site, as positive air samples were orally gavaged into pigs.  Other studies 
have successfully housed PED positive pigs in very close proximity to negative pigs and did not 
cause viral transmission as long as direct/indirect contact between the positive and negative pigs 
was avoided (86, 87), suggesting that aerosolization of PEDV may not play a large role in 
transmission. 
The exact route of PEDV introduction into the US is not known, and likely will remain 
unknown.  However, its simultaneous introduction into several premises with excellent 
biosecurity during the initial outbreak led many to look to feed as the vehicle of transmission for 
the virus (88).  A proof of concept of contaminated complete feed as a fomite for PEDV 
transmission was demonstrated (89, 90), and a report from an early case in Ohio implicated a 
pelleted piglet diet as the source of infection (91).  Spray dried porcine plasma (SDPP), a 
component of hog feed, was implicated as a potential source of PEDV introduction into Canada 
(66, 92).  However, other reports have demonstrated the efficacy of the spray drying process in 
inactivating PEDV (93, 94).  Another study showed the contamination of livestock trailers with 
PEDV at bottlenecks in production such as harvest facilities and livestock auctions, 
demonstrating their potential as fomites in the spread of PEDV (95).  Regardless of what the 
route of initial introduction into a previously unaffected area is, once PEDV is introduced, a 
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strong spatio-temporal clustering pattern of infected premises emerges.  This suggests that 
indirect transmission, whether through fomites or aerosol, is responsible for the local 
transmission of PEDV (96, 97). 
 
Infection and Pathogenesis 
Host Range and Cellular Tropism 
There are many coronaviruses affecting both mammalian and avian species.  Some infect 
multiple species, while others are limited to one host species.  To date, PEDV has only been 
shown to infect swine (98); however, intestinal epithelial cells derived from other species have 
been infected with PEDV in vitro (99).  Coronaviruses generally target host respiratory and/or 
enteric epithelium.  PEDV primarily targets porcine enterocytes.  However, recent reports have 
shown the replication of PEDV in porcine alveolar macrophages as well as porcine monocyte-
derived dendritic cells (100, 101). 
 
Cell Entry 
The S protein of coronaviruses is a class I fusion protein.  The S1 domain is responsible 
for receptor binding, while the S2 domain comprises the membrane fusion machinery.  In an 
effort to prevent early inappropriate triggering of this fusion mechanism, the S protein exists in a 
“locked conformation” (102).  For the exposure of the fusion peptide and subsequent fusion of 
viral envelope and cell membrane to occur, a site at the junction of the S1 and S2 domains must 
be proteolytically cleaved (103).  For some coronaviruses, such as Severe Acute Respiratory 
Syndrome coronavirus (SARS-CoV), this cleavage event is performed by intracellular 
endosomal proteases prior to viral release (104).  For PEDV, cleavage is only accomplished with 
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exogenous proteases i.e. trypsin.  Interestingly, for this to occur in PEDV, the S1 domain must 
first bind to its receptor, which thereby theoretically exposes the cleavage site (102).  However, 
trypsin independent cell entry has been accomplished by both serial passage in Vero cells as well 
as a single point mutation in the S2 domain of the S protein (40, 105). 
The functional receptor of most alphacoronaviruses is Aminopeptidase N (APN), also 
designated as cluster of differentiation 13 (CD13).  This is the case for several important swine 
alphacoronaviruses including TGEV, PRCoV, and PEDV (34, 106).  APN is a zinc binding 
protease involved in pain management, vasopressin release, cell proliferation and immunity in 
host tissues (107), however the enzymatic properties of APN do not appear necessary for virus 
entry (108).  Animals previously resistant to PEDV infection are rendered susceptible after 
transgenic expression of porcine APN (pAPN) (109).  Similarly, introduction of soluble pAPN 
into non-susceptible animals increased their anti-PEDV antibody production (110).  Intestinal 
epithelial cells mature in a polarized manner (111), resulting in pAPN localization onto the 
apical surface of the plasma membrane (112).  As a result, PEDV entry and release is restricted 
to this area (112).  The use of sugar co-receptors has been suggested to play a role in the enteric 
tropism of other swine coronaviruses (113).  PEDV’s recognition of N-acetylneuraminic acid 
had been suggested to perform a similar function (103). 
 
Viral replication and release 
After membrane fusion and nucleocapsid delivery into the cell cytoplasm, pp1a and 
pp1ab are translated from ORFs 1a and 1b.  These are proteolytically cleaved and assemble to 
form the RTC as previously described.  The RTC subsequently transcribes negative sense full 
length genomic RNA along with 5 negative sense subgenomic RNAs corresponding to ORF 3 
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and proteins S, E, M, and N.  These negative sense RNA transcripts are used as templates by the 
RTC to form positive sense genomic and subgenomic RNA.  The subgenomic RNAs are 
translated to synthesize the protein coded by the ORF at their 5’ most end.  Structural proteins S, 
E, and M insert into the endoplasmic reticulum, while N proteins binds to the full length positive 
sense genomic RNA to form a helical nucleocapsid.  This nucleocapsid then buds through the 
Endoplasmic Reticulum-Golgi intermediate compartment (ERIC) forming virion filled smooth 
walled vesicles.  These vesicles fuse to the plasma membrane, thereby releasing virions from the 
host cell (7, 32). 
 
Gross and Histopathologic Lesions 
Gross lesions observed with PEDV infection are typical for an atrophic enteritis, 
including transparent thin walled small intestines with watery content (114, 115).  
Immunohistochemical (IHC) staining shows PEDV primarily targets mature villous enterocytes, 
with occasional staining in replicating crypt cells (63).  Madson et al. described microscopic 
changes as “superficial villous enterocyte swelling with minimal cytoplasmic vacuolation and 
karyomegaly, necrosis of scattered enterocytes, enterocyte attenuation, sloughing of degenerate 
and necrotic enterocytes, contraction of subjacent villous lamina propria containing apoptotic 
cells admixed with scattered neutrophils and lymphocytes, and crypt cell hyperplasia” (115).  
The contraction of the villous lamina propria and hyperplasia of crypt cells in response to PEDV 
infection are evidenced structurally as reduced villous height and increased crypt depth.  This is 
often quantified as the villous height to crypt depth ratio.  Decreases in this ratio are observed in 
duodenum, jejunum, and ileum tissue sections from infected pigs (65, 86, 115-117).  This pattern 
of microscopic lesions is typical of a viral enteritis, and is not distinguishable from those caused 
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by TGEV or a severe rotavirus infection.  Although PEDV viral antigen could be detected by 
IHC or immunofluorescence staining in small intestine, cecum, colon, mesenteric lymph node, 
and some spleen tissues, PEDV-related microscopic lesions were only apparent in small 
intestines (65, 116-118).  Microscopic lesions or IHC staining were not observed in other non-
enteric tissues (such as tonsil, heart, lung, liver, kidney, and muscle) of PEDV-infected pigs 
although low level of PEDV RNA could be detected from these tissues (65, 117).   
 
Clinical Signs/viral shedding 
 Virulent PEDV infection results in anorexia, lethargy, and severe watery diarrhea as early 
as 1 day post inoculation (DPI) in conventional neonatal piglets or in 1-day-old cesarean-derived 
colostrum-deprived piglets (117).  Diarrhea is likely a result of several factors including: loss of 
enterocytes and dysfunction of remaining enterocytes leading to malabsorption, reduction in 
membrane bound digestive enzymes leading to maldigestion, and decreased gut integrity due to 
loss of junction proteins leading to increased water loss into the gut lumen (114, 115, 117, 119, 
120).  Vomiting is also often described in the early stages of infection, but mechanisms behind 
this has not been elucidated.  Electrolyte derangements observed in PEDV infected pigs include 
hypernatremia, hyperkalemia, hyperchloremia, with hypocalcemia and decreased bicarbonate 
(114).  Body temperatures are reduced during the acute stages of infection, resulting in heat 
seeking behavior.  In the field this is often seen as suckling pigs lying on top of sows.  A 
significant reduction in average daily gain (ADG) have been demonstrated in weaned pigs in the 
first week of infection, but not thereafter (115).  It is unclear whether or not this translates to an 
increase in time to market weight.  Electrolyte derangement and dehydration due to diarrhea 
often lead to death in affected pigs.  Mortality rates may approach 100% in naïve neonatal pigs, 
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and decreases generally with age.  Virus is detectable in feces as early as 12 hours post 
inoculation by RT-PCR, and is generally cleared by 21-28 DPI (86, 114, 115). 
 
Age dependent susceptibility 
 Early reports of PEDV in Europe described suckling pigs as unaffected by the disease 
(121).  However, over time researchers began to observe more severe clinical disease in suckling 
pigs (115, 117, 122, 123).  The reason/mechanism for this adaptation over time to younger hosts 
has not been described.    Possible reasons for this increased susceptibility of neonatal pigs 
includes: longer intestinal villi comprised of more mature permissive enterocytes (124), 
increased susceptibility to electrolyte derangement/water loss (125), and a less mature immune 
system as demonstrated by lower phagocytic capabilities and decreased IFN-α levels   (125-128).  
Another likely contributing factor is the time it takes for a replicating crypt cell to become a 
mature enterocyte: 7-10 days in neonatal pigs vs 2-4 days in weaned pigs as described by Moon 
et al. in 1971 (129).  This idea was recently supported by Jung et al. (123) who demonstrated 
decreased markers of crypt cell proliferation (LGR5+ and Ki67) in neonatal pigs compared to 
weaned pigs. 
 
Virus strain dependent virulence differences 
The genetic diversity of PEDV strains likely results in differences in virulence.  Global 
PEDV strains have not been head-to-head compared for their virulence differences in 
experimentally infected pigs.  However, since PEDV emerged in the US in 2013, a number of 
studies have been conducted to evaluate pathogenicity of US PEDVs.  The US PEDV prototype 
strain has been experimentally confirmed as highly virulent in gnotobiotic (116), cesarean-
15 
 
derived-colostrum-deprived (CDCD) (117, 130), and conventional pigs (65, 86, 115, 123).  
Recent experimental studies demonstrate that the US S-INDEL-variant PEDVs overall had lower 
pathogenicity compared to the US prototype strains in 3-4 day old pigs or 5-day old pigs or 1-
week old pigs (65, 73, 76).  However, the virulence of S-INDEL PEDVs observed in the field 
varies among farms and countries (71, 78).  Further investigations of pathogenicity of S-INDEL 
PEDV variants in pigs at different ages are warranted.  
 
Immune Response to PEDV Infection 
Innate Immunity 
Innate immunity plays a very important role in the pathology of viral infections.  The 
interplay between this first line of defense and a virus’s ability to evade it will set the stage for 
the development of clinical disease caused by a particular virus.  Viral components are largely 
host derived, which can make recognition by the host difficult.  Recognition of viral nucleic acid 
as a pathogen-associated molecular pattern (PAMP) is one method utilized by a host’s innate 
immune system to determine that a viral invasion has occurred and to initiate an antiviral 
response.  Recognition of double stranded RNA (dsRNA, a replicative intermediate of RNA 
viruses) by cytoplasm associated sensor proteins such as retinoic acid-inducible gene 1 (RIG-1) 
and melanoma differentiation associated protein 5 (MDA-5), or membrane associated Toll Like 
Receptors (TLRs), is often the first step in this process (131).  This signal is then relayed through 
specific downstream kinases leading to the activation of transcription factors: interferon 
regulatory factor 3 (IRF3), activating transcription regulatory factor c-Jun (ATF-2/c-Jun), and 
nuclear factor κβ (NF-κβ).  These transcription factors work in concert to increase expression of 
type 1 interferons (IFN-α/β), which work through many mechanisms to create an antiviral state 
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in the host (132).  Coronaviruses as a group generally do not induce high levels of IFN- α/β in 
their hosts (133).  Many different mechanisms have been described by which these viruses 
inhibit IFN-α/β production via both non-structural and structural viral proteins (134-136).  
PEDV’s  NSPs 1, 3, 5, 7, 14, 15, 16, as well as structural proteins E, M, N, and the accessory 
protein coded by ORF 3 have all been demonstrated to inhibit IFN- β production(137, 138).  The 
mechanism by which this occurs has been well described for NSPs 1, 3, 5, and N.  NSP1 has 
been shown to degrade CREB binding protein (CBP) and thereby inhibit activation of the 
transcription factor IRF3 (137).  Inhibition of IRF3 has also been demonstrated by PEDV N 
protein, which prevents its phosphorylation and nuclear translocation (49).   Xing et. al. 
demonstrated that the papain like protease 2 (PLP2) domain on NSP3 of PEDV functioned as a 
deubiquitinase (DUB), and was thereby able to inhibit RIG-1 and the stimulator of interferon 
genes (STING) protein, effectively blocking the expression of IFN-β (139).  The papain like 
protease 1 (PLP1) domain of NSP3 of PEDV, however, was shown not to share this function.  
NSP5, also known as the 3-C like protease (3CLPro), inhibits activation of NF-κβ through 
proteolytic cleavage of the NF-κβ essential modulator (NEMO) protein (138).  PEDV does not 
completely inhibit NF-κβ, as it is still activated by the N protein via TLR’s 2, 3, and 9 (140).  
NF-κβ regulates the expression of Interleukin 8 (IL-8) (141), which serves as a chemotactic 
factor for neutrophils as well as other granulocytes to move to the site of infection.  Both the N 
and E protein of PEDV have been demonstrated to upregulate IL-8 expression through 
endoplasmic reticulum (ER) stress in host cells (142, 143).  Interestingly the N protein was also 
shown to prolong the S phase of the host cell cycle, although the exact mechanism behind this 
has not been elucidated (143). 
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Apoptosis of virally infected cells is often employed by a host’s innate immune system to 
limit viral replication.  In response some viruses have developed mechanisms to inhibit 
apoptosis, while others have developed systems to promote apoptosis and thereby abet the 
release of progeny virions (144).  The immunomodulation of PEDV appears to promote 
apoptosis through mitochondrial apoptosis inducing factor (AIF) (145, 146).  Blocking this 
pathway in vitro was found to reduce viral replication by 90%, demonstrating its importance in 
the pathophysiology of PEDV infection (145). 
Natural Killer cells (NKC), a type of lymphocyte, play an important role in innate 
immune responses to viral infections.  These cells as well as other components of the innate 
immune system of neonates are not fully functional at birth (147-150).  Annamalai et. al. 
demonstrated that PEDV infected suckling pigs had fewer NKCs, less NKC activity, and fewer 
IFN-λ producing NKCs than infected weaned pigs (151).  This data correlates well with the 
difference in susceptibility of suckling pigs and weaned pigs to PEDV demonstrated by our 
group (86). 
 
Humoral Immunity 
Humoral immunity involves the production of several classes of immunoglobulins by B 
lymphocytes.  The IgA class of immunoglobulins plays an important role in the immune 
response to enteric pathogens such as PEDV.  Its production and secretion onto mucosal surfaces 
allows for virus neutralization, opsonization, and antibody dependent cellular cytotoxicity 
(ADCC) against virally infected cells (152).  IgA is detectable in serum as early as 12-15 days 
post PEDV challenge, with peak levels reached at 21 days post exposure.  IgA secreting 
lymphocytes are detectable in the lamina propria of the small intestine by 21 days as well (153).  
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The presence of both of these has been correlated to the development of a protective immune 
response against a homologous PEDV challenge (154).  IgG titers appear in pigs at nearly the 
same time as IgA (153).  Serum neutralizing titers, however, have been demonstrated as early as 
7 days post challenge (86).  This correlates well to the earliest detection of an IgM titer 
demonstrated by de Arriba et al. (153).   PEDV infection, however, is most severe in neonatal 
pigs whose immune systems are immature and who are too young to have had time to develop an 
antibody response against PEDV.  In addition, due to the histological structure of swine placenta, in 
utero transfer of immunoglobulins from dam to fetus does not occur (155).  Thus, maternal immunity 
especially the production of IgA in milk has been the focus of providing protection to neonatal 
pigs.  Producers have tried various strategies to increase maternal immunity in sows, including 
attenuated live vaccines, killed vaccines, subunit vaccines, and “feeding back” of infected tissues 
from clinically affected animals on the same farm (114).  The route by which dams are exposed 
affects the characteristics of the immune response they subsequently develop.  Exposure via a 
mucosal surface (i.e. oral or intranasal exposure) will lead to increased IgA production (152).  
However, there is evidence of compartmentalization of the mucosal immune response, such that 
oral exposure to enteric pathogens stimulates lymphocytes associated with the GI mucosa better 
than intranasal exposure (156).  Parenterally/systemically immunized sows will also deliver IgG 
to their offspring through colostrum for a short period immediately after parturition, which may 
offer some protection if titers are high enough. 
 The neutralizing epitope(s) for PEDV are thought to locate in the spike protein, just as 
they do for Transmissible Gastroenteritis Virus (TGEV), another swine enteric coronavirus (35).  
Several potential epitopes have been identified in the highly variable S1 region (39, 157, 158).  
Others have been identified in the endodomain of the more conserved S2 region (36, 159). 
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Cell Mediated Immunity 
 Viral replication and assembly occurs within host cells, which limits exposure to 
antibody.  Other mechanisms of immunity are often necessary to clear viral infections.  While 
cell mediated immunity is likely involved in the immune response to PEDV, it has not been 
described as extensively as the innate and humoral responses.  However, De Arriba et al did 
show an increase in T helper cells (CD4+ cells) in the mesenteric lymph nodes of pigs 4 days 
after challenge with a virulent CV777 strain of PEDV (160).  CD4+ cells work in concert with 
dendritic cells to activate cytotoxic T cells (CD8+ cells), macrophages, and stimulate antibody 
production by B lymphocytes.  Peak levels of CD4+ cells in mesenteric lymph nodes occurred at 
21 days post infection, correlating with peak IgG and IgA antibody production.  This suggests 
that cell mediated immunity may play an important role in the development of a protective titer 
against PEDV (160).  PEDV is able to infect monocyte derived dendritic cells (Mo-DCs) in 
vitro.  Doing so resulted in increased IL-12 production by Mo-DCs and IFN-γ production by 
CD4+ cells, further demonstrating the importance of cell mediated immunity as a component of 
the host’s immune response to PEDV (101). 
 
Diagnosis of Infection 
 Clinical signs of PEDV include watery diarrhea, vomiting, heat seeking behavior, as well 
as others.  These signs, however, are not unique to PEDV, making diagnosis by clinical 
presentation impossible.  Multiple swine diarrheal diseases also cause an atrophic enteritis, 
making diagnosis by histopathology impossible as well.  Electron microscopy (EM) has been 
used in the identification of PEDV, especially early on in outbreaks when other methods of 
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detection are not yet available (63, 161, 162).  Two other common swine enteric pathogens, 
TGEV and Porcine Deltacoronavirus (PDCoV), are also coronaviruses, making definitive 
diagnosis by EM alone impossible. 
Specific methods of detection are available for PEDV and include virus isolation (VI), 
immunofluorescence assays (FA and IFA), enzyme linked immunosorbent assays (ELISA’s), 
immunohistochemistry (IHC), in situ hybridization (ISH), and reverse transcription polymerase 
chain reactions (RT-PCR).  Virus isolation of PEDV traditionally has a very low rate of success 
(50), making it a poorly sensitive diagnostic assay.  Immunofluorescence assays can be used to 
identify PEDV in tissue culture as well as clinical samples (86, 116).  Commercial antigen 
ELISA kits are available in other countries, and may have potential as a rapid pen-side detection 
method for PEDV although the sensitivity could be lower than real-time RT-PCRs (163, 164).  
ISH has been used experimentally, but is not a commonly used method of detection on clinical 
samples (165).  IHC is widely used to identify PEDV within specific histopathologic lesions (65, 
115, 117).  This allows to definitively link PEDV to the clinical disease observed.  PEDV RT-
PCRs are the most common method for viral detection. They are highly sensitive, high-
throughput assays with a rapid turnaround time, making them ideal for identification of PEDV 
from clinical samples.  Various genes have been used as targets for this assay including the N, 
M, and S2 genes and so on.  While all target highly conserved genes, a recent study showed that 
an N gene based RT-PCR was slightly more sensitive than a S2 based RT-PCR for PEDV 
detection (166).   
PEDV serological assays can be used to determine a herd’s recent/past exposure to the 
virus.  They can also be used as a metric to determine the immune response/protection after 
exposure to vaccine or wild type virus.  These assays include immunofluorescence antibody 
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(IFA) assays, various ELISAs based on different viral proteins, virus neutralization (VN) tests or 
fluorescent focus neutralization (FFN) tests, and fluorescent microsphere immunoassays 
(FMIA).   
VN and FFN tests have been used in some studies (74, 86, 167-169) to assess levels of 
PEDV neutralizing antibodies in serum, milk or colostrum samples and have the added benefit of 
quantifying the functional neutralizing ability of an animal’s antibody titer.  They are however a 
fairly time consuming assay, and are unable to differentiate specific isotypes of antibody.  IFA 
and ELISA have a much more rapid turnaround time and allow for isotype differentiation.  This 
is particularly important for PEDV as the detection of IgA specifically is thought to be an 
important metric of mucosal/maternal immunity.  In addition, ELISA is a high-throughput assay 
making it suitable for testing a large number of samples.  The whole virus-based ELISA (86), 
recombinant S1 protein-based ELISAs (74, 170-172), recombinant membrane protein-based 
ELISA (173), and recombinant nucleocapsid protein-based ELISA (167) have been developed 
for the detection of PEDV antibody.  The FMIA is a bead-based high-throughput assay and is 
useful for simultaneous detection of antibodies against multiple pathogens (167).   
In summary, each PEDV serological assay has its advantages and limitations.  Selection 
of appropriate serological assays depends on the objectives of a particular study.  IFA, ELISA 
and FMIA assays are useful in determining whether pigs were previously exposed to PEDV 
infection or whether piglets have acquired maternal antibodies from their dams.  In addition, 
these assays could determine the isotype of antibodies.  A study showed that IFA, ELISA and 
FMIA had strong correlations in determining PEDV antibodies (167).  However, another report 
indicated that a whole virus-based PEDV ELISA could detect PEDV IgG antibodies longer than 
an IFA assay in infected pigs (174).  VN and FFN tests measure neutralizing antibodies that 
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could provide protection against virus infection.  Although serum neutralizing antibodies may 
not provide direct protection against an enteric pathogen such as PEDV, a study showed 
correlations of neutralizing antibodies detected in the serum and in milk and colostrum of 
previously exposed or vaccinated sows (167).  It has been demonstrated that IFA, VN or FFN, 
and various ELISA assays can detect antibodies against both US prototype and S-INDEL-variant 
PEDVs (74, 175). 
 
Prevention and Control 
Control of PEDV in commercial herds is accomplished in the field through a variety of 
methods including: strict biosecurity, vaccination, and controlled exposure. 
Strict biosecurity protocols were in place in most US commercial barns prior to the 
introduction of PEDV to prevent the spread of other pathogens especially PRRSV.  These 
include shower-in/shower-out facilities, disinfection of all fomites coming onto the property, 
limiting traffic on and off farm, heat treatment/disinfection of livestock trailers, as well as others.  
However, farms with seemingly strong and effective biosecurity protocols were affected by the 
PEDV outbreak (63).  PEDV has previously been shown to be sensitive to ether and chloroform 
disinfectants and to inactivate at a pH outside the range of 4-9 (32, 176).  More recent studies 
have found that accelerated hydrogen peroxide (Accel©) is an effective disinfectant against 
PEDV even while feces were present (177).  It was also found that time and temperature 
combinations of 71º C for 10 minutes or 20º C for 1 week were capable of inactivating PEDV in 
the presence of feces (87, 177).  All of this data provides valuable information for trailer baking 
and disinfection processes on commercial farms. 
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On sow farms, vaccination strategies typically involve vaccination of females prior to 
farrowing to stimulate lactogenic immunity to PEDV that is transferred via colostrum and milk 
to suckling piglets.  In weaned pigs, maternally-derived antibodies gradually wane and 
vaccination of weaned pigs may boost PEDV antibody production and provide active protection 
(178).  Several cell culture attenuated virus strains have been used as vaccines in Asia including 
CV777, 93P-5, DR-13, and SM98-1 to varying degrees of success (32, 38, 179, 180).  Numerous 
killed vaccines are also in use across Asia.  Interestingly one study found that a killed SM98 
resulted in a higher neutralizing titer than a modified live vaccine based on the same strain (181).  
In the U.S. two conditionally licensed vaccines are available, a killed virus vaccine from Zoetis, 
and an RNA particle vaccine from Harris Vaccines.  Studies have shown that these PEDV 
vaccines induced good IgG and IgA immune responses in herds previously exposed to PEDV but 
did not induce good IgA responses in naïve pigs after vaccination (168, 169).  Modified live 
virus vaccines based on the contemporary US PEDV strains are currently under development. 
In the event of an outbreak on a sow farm, with absence of a safe and effective PEDV 
vaccine, most of the control strategies involve controlled exposure (feedback) of pregnant sows 
to wild type virus.  This is generally accomplished by feeding back infected tissues and/or feces 
from piglets to pregnant sows at some interval prefarrowing.  This practice has a great deal of 
variability in how it is executed, which leads to a great deal of variability in its effectiveness in 
providing protective immunity to piglets (182).  It is important to note that materials used for 
feedback may contain other pathogens such as PRRSV and/or PCV2 and may pose a potential 
risk of unintentionally infecting pigs with these pathogens. 
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Conclusions and Objectives of This Thesis 
Tremendous knowledge on PEDV has been learned especially since PEDV emergence in 
the US in 2013.  However, before the project described in this thesis was started, no information 
had been published regarding the minimum infectious dose of PEDV in pigs at different stages 
of production.  Correlations of PEDV infectious titers to the real-time RT-PCR cycle threshold 
(Ct) values had not been described either.  Thus, the objectives of this research were to: 1) 
correlate PEDV RT-PCR Ct values to infectious titers of the virus; 2) determine the minimum 
infectious dose of PEDV in naïve neonatal piglets; 3) determine the infectious dose of PEDV in 
naïve weaned pigs and to assess their corresponding antibody responses.  Applications of these 
research data to the interpretation of the clinical relevance of PEDV diagnostic results and to 
development of a sensitive swine bioassay model for PEDV are discussed. 
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Abstract 
Porcine epidemic diarrhea virus (PEDV) was identified in the United States (U.S.) swine 
population for the first time in April 2013 and rapidly spread nationwide.  However, no information 
has been published regarding the minimum infectious dose (MID) of PEDV in different pig 
models. The main objective of this study was to determine the oral minimum infectious dose of 
PEDV in naïve conventional neonatal piglets and weaned pigs. A U.S. virulent PEDV prototype 
isolate (USA/IA/2013/19338) with known infectious titer was serially ten-fold diluted in virus-
negative cell culture media. Dilutions with theoretical infectious titers from 560 to 0.0056 
TCID50/ml together with a media control were orogastrically inoculated (10ml/pig) into 7 groups 
of 5-day-old neonatal pigs (n=4 per group) and 7 groups of 21-day-old weaned pigs (n=6 per 
group).  In 5-day-old pigs, 10ml of inoculum having titers 560 – 0.056 TCID50/ml, corresponding 
to polymerase chain reaction (PCR) cycle threshold (Ct) values 24.2 – 37.6, resulted in 100% 
infection in each group; 10ml of inoculum with titer 0.0056 TCID50/ml (Ct>45) caused infection 
in 25% of the inoculated pigs. In 21-day-old pigs, 10ml of inoculum with titers 560 – 5.6 TCID50/ml 
(Ct 24.2 – 31.4) resulted in 100% infection in each group while 10ml of inoculum with titers 0.56 
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– 0.0056 TCID50/ml (Ct values 35.3 – >45) did not establish infection in any pigs under study 
conditions as determined by clinical signs, PCR, histopathology, immunohistochemistry, and 
antibody response. These data reveal that PEDV infectious dose is age-dependent with a 
significantly lower MID for neonatal pigs compared to weaned pigs. This information should be 
taken into consideration when interpreting clinical relevance of PEDV PCR results and when 
designing a PEDV bioassay model. The observation of such a low MID in neonates also 
emphasizes the importance of strict biosecurity and thorough cleaning/disinfection on sow farms. 
 
Keywords: porcine epidemic diarrhea virus; PEDV; quantitative PCR; infectious dose; neonatal 
pigs; weaned pigs 
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Introduction 
Porcine epidemic diarrhea virus (PEDV), the causative agent of porcine epidemic diarrhea 
(PED), is an enveloped positive-sense, single-stranded RNA virus belonging to the order 
Nidovirale, family Coronaviridae, subfamily Coronavirinae, genus Alphacoronavirus [1].  PEDV 
was identified in 1978 [2, 3] although the disease was first recognized in England in 1971 [4].  
PEDV caused widespread epidemics in several European countries during the 1970s and 1980s [5, 
6]; however, since the 1990s PED has become rare in Europe with occasional outbreaks [7].  PED 
was first reported in Japan in 1982 and has since been confirmed in other Asian countries such as 
South Korea, China, Thailand, and Vietnam [5, 8, 9].  PEDV was detected in the United States 
(U.S.) for the first time in April 2013 [10].  So far, at least two genetically different PEDV strains 
have been identified in the U.S. (U.S. PEDV prototype strain and S-INDEL-variant strain) [11, 
12].  After the PED outbreak in the U.S., detection of U.S. prototype-like PEDV has been reported 
in Canada, Mexico, Taiwan, and South Korea [11, 13-15]; detection of U.S. S-INDEL-variant-like 
PEDV has been reported in South Korea, Germany, Belgium and France [16-20].  
Since its emergence in the U.S., PEDV has spread rapidly across the country and resulted in 
the estimated death of over 7 million pigs in the first year [21], causing substantial economic losses.  
PED in U.S. swine is characterized by watery diarrhea, dehydration, variable vomiting, high 
mortality in neonatal piglets, and high morbidity but low mortality in weaned pigs [10].  The rapid 
spread of PEDV suggests that the virus is highly transmissible.  However, no information has been 
published regarding the minimum infectious dose (MID; the smallest quantity of virus to establish 
infection) of PEDV in pigs at different stages of production. 
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Real-time RT-PCR (rRT-PCR) has been widely used for PEDV detection and diagnosis. 
However, correlations of PEDV infectious titers to the rRT-PCR cycle threshold (Ct) values have 
not been described.  Virus isolation has generally been used to assess if a live virus is present in 
samples.  But for PEDV, the success rate of virus isolation in cell culture has been quite low [22].  
Currently, swine bioassay remains the most reliable means to determine if infectious PEDV is 
present in a clinical specimen or if "X" treatment will inactivate the virus.  However, there remains 
inconsistency in selecting swine models for bioassay.   
The objectives of this study were to 1) determine the minimum infectious dose of PEDV in 
naïve conventional neonatal piglets and weaned pigs; 2) determine the correlation of PEDV PCR 
Ct values to the infectious titers.  Applications of these research data to the interpretation of the 
clinical relevance of PEDV diagnostic results and to development of a sensitive swine bioassay 
model for PEDV are discussed. 
 
Materials and Methods 
Virus and cells   
A U.S. PEDV prototype strain cell culture isolate USA/IA/2013/19338 was isolated and 
propagated in Vero cells (ATCC CCL-81) in our lab as previously described [22].  A virus stock 
at the 7th passage in cell culture was prepared and used in this study.  The virus stock was 10-fold 
serially diluted in post-inoculation media (Minimum Essential Medium supplemented with 0.3% 
tryptose phosphate broth, 0.02% yeast extract, 5 µg/ml of trypsin 250, 10 unit/ml penicillin, 10 
µg/ml streptomycin, 0.05 mg/ml gentamicin, and 0.25 µg/ml amphotericin B) to obtain 10-1 to 10-
10 dilutions (Table 3.1). The post-inoculation medium without virus was used as a negative control.  
Multiple aliquots of each dilution were prepared and stored at -80°C so that quantification of these 
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virus dilutions and inoculation into pigs could be performed under the same number of freeze/thaw 
cycles.  
 
Virus titration   
The virus stock and serial dilutions were back titrated in Vero cells to determine their 
infectious titers in the unit of median tissue culture infective dose per milliliter (TCID50/ml) and  
plaque forming unit per milliliter (PFU/ml).  To determine TCID50/ml, each sample was serially 
10-fold diluted in post-inoculation media and inoculated into Vero cells grown in 96-well plates, 
100µl per well, triplicate wells per dilution.  The plates were incubated at 37°C with 5% CO2 for 
5 days.  Viral cytopathic effects (CPE) were recorded daily.  After 5-day inoculation, the plates 
were subjected to immunofluorescence staining using a monoclonal antibody conjugate SD6-29 
against the PEDV nucleocapsid protein (SD-1F-1, Medgene Labs, Brookings, South Dakota, 
USA). The virus titers were determined according to the method described by Reed and Muench 
[23] and expressed as TCID50/ml.  To determine PFU/ml, each sample was serially 10-fold diluted 
in post-inoculation media and inoculated into Vero cells grown in 6-well plates, 500µl per well, 
duplicate wells per dilution.  After incubation at 37°C for 1 h, 4ml of overlay medium (post-
inoculation media supplemented with 0.75% carboxymethyl cellulose) was added to each well.  
The plates were then incubated undisturbed at 37°C with 5% CO2 for 4 days.  The media were 
discarded and the plates were stained with crystal violet in 10% buffered formalin.  The bottoms 
of the plates were then illuminated.  Wells containing 20-200 plaques were counted and titers 
expressed as PFU/ml. 
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RNA extraction 
Nucleic acids were extracted from virus dilutions, rectal swabs, and tissue homogenates 
using a MagMAX Pathogen RNA/DNA Kit (Thermo Fisher Scientific, Waltham, Massachusetts, 
USA) and a Kingfisher-96 instrument (Thermo Fisher Scientific) following the instructions of the 
manufacturer. 
 
Quantitative real-time RT-PCR for PEDV 
A PEDV nucleocapsid (N) gene-based real-time RT-PCR was previously developed at the 
Iowa State University Veterinary Diagnostic Laboratory (ISU VDL) [24, 25].  On the basis of the 
PEDV N gene-based rRT-PCR, a quantitative rRT-PCR to determine genomic copies/ml of PEDV 
in a sample was developed in this study.  
To generate in vitro transcribed RNA standards, a fragment covering the PEDV N gene-
based RT-PCR products (nucleotide positions 26,679-26,885 of the PEDV USA/IN/2013/19338, 
GenBank # KF650371) flanked by restriction sites EcoRI and HindIII at its 5’ and 3’ end, 
respectively, was cloned into the plasmid vector pIDTBlue to obtain the plasmid 
pIDTBlue:PEDV_N_IVT (IDT, Coralville, Iowa, USA) in which the PEDV N gene products were 
located downstream of the bacteriophage T7 RNA polymerase promoter.  The recombinant 
plasmids were transformed into One Shot® TOP10 chemically competent Escherichia coli cells 
(Thermo Fisher Scientific) and propagated following the instruction manual.  The plasmids were 
extracted using a QIAprep® Spin Miniprep Kit (Qiagen, Valencia, California, USA) according to 
the manufacturer’s instructions.  The plasmid DNA was linearized with HindIII, treated with 
Proteinase K, purified with QIAquick® PCR purification kit (Qiagen), and resuspended in 
nuclease-free water.  The linearized DNA was subject to run-off in vitro transcription into RNA 
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using a MEGAshortscriptTM T7 Transcription Kit (Thermo Fisher Scientific) followed by 
purification using a MEGAclearTM Transcription Clean-up Kit (Thermo Fisher Scientific) 
according to the instruction manuals provided with the kit.  The in vitro transcribed RNA was 
quantified using a BioSpectrometer (Eppendorf, Enfield, Connecticut, USA).   
The in vitro transcribed RNA was 10-fold serially diluted in nuclease-free water and used as 
standards in the PEDV N gene-based rRT-PCR to generate standard curves and quantify viral loads 
in test samples.  Five µl of each RNA template was used in PCR setup in a 25µl total reaction 
using Path-ID™ Multiplex One-Step RT-PCR Kit (Thermo Fisher Scientific) as previously 
published [24, 25].  Amplification reactions were performed on an ABI 7500 Fast instrument 
(Thermo Fisher Scientific, Waltham, Massachusetts, USA) with the following conditions: 1 cycle 
of 48°C for 10 min, 1 cycle of 95°C for 10 min, and 45 cycles of 95°C for 15 sec and 60°C for 45 
sec.  After generating 22 standard curves, the Ct values were averaged (means determined) and an 
equation of X = 10(Ct-47.262)/-3.3969, where X=genomic copies/ml, was developed to transform the Ct 
values into estimated genomic copies of PEDV RNA per ml in test samples under the PCR 
conditions of this study.              
 
Ethics statement 
The experimental protocol for the pig studies was approved by the Iowa State University 
Institutional Animal Care and Use Committee (IACUC, Approval No. 4-14-7777-S; approved on 
24th of April 2014).  
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Neonatal pig study design   
Twenty-eight 5-day-old piglets purchased from a conventional breeding farm were tested at 
the ISU VDL and confirmed negative for PEDV, porcine deltacoronavirus (PDCoV), transmissible 
gastroenteritis virus (TGEV), and porcine rotaviruses (groups A, B, & C) by virus-specific PCRs 
on rectal swabs and negative for PEDV antibody by a virus-specific indirect fluorescent antibody 
(IFA) assay on serum samples.  Upon arrival at the Iowa State University Laboratory Animal 
Resources (LAR) facilities, all pigs were administered an intramuscular injection of Excede® 
(Zoetis, Florham Park, New Jersey, USA) per label instructions.  Pigs were randomized by weight 
into 7 groups of 4 pigs each, one room per group.  Within each group, pigs were housed in tubs 
with solid dividers completely separating each of the 4 pigs from one another.  Each divided 
portion of the tub had dedicated water sources (Fig 3.1).  Pigs were fed a mixture of Esbilac liquid 
milk replacer and yogurt and had free access to water.   
After 1 day acclimation (piglets were 6 days old), pigs in groups 1-7 were orogastrically 
inoculated with 10-3, 10-4, 10-5, 10-6, 10-7, and 10-8 dilutions of the PEDV stock and the virus-
negative cell culture media, respectively, using a size 8 French feeding tube and 60ml syringe 
(10ml/pig) (Table 3.2).  Piglets were evaluated daily for clinical signs of vomiting, diarrhea, 
lethargy, and body condition.  Diarrhea severity was assessed with the following criteria by both 
visual observation and rectal swabbing: ‘normal’=no diarrhea, ‘mild diarrhea’=soft (cowpie), 
‘moderate diarrhea’=liquid with some solid content, ‘watery diarrhea’=watery with no solid 
content.  Rectal swabs were collected daily from each pig from 0 day post inoculation (DPI) until 
necropsy and were submerged into 1ml phosphate buffered saline (PBS, 1× pH 7.4) immediately 
after collection.  Serum was collected before inoculation and at necropsy.  Duration of the study 
was designed to be 0-7 DPI.  However, per IACUC protocol, pigs with severe clinical signs were 
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euthanized and necropsied at 4 DPI and the remaining pigs were kept through 7 DPI for necropsy 
(Table 3.2).  At necropsy, intestinal tissues and contents were grossly evaluated.  Fresh proximal 
jejunum, middle jejunum, distal jejunum, ileum, cecum and colon were collected, along with 
cecum content.  Additionally, a portion of the three sections of jejunum, and ileum were fixed in 
10% neutral buffered formalin.  Rectal swabs and cecum contents were tested by aforementioned 
quantitative PEDV N gene-based rRT-PCR.  Formalin-fixed jejunum and ileum were submitted to 
the ISU VDL for histopathology and immunohistochemistry examinations. 
 
Weaned pig study design   
Forty-two 3-week-old pigs purchased from a conventional breeding farm were tested at the 
ISU VDL and confirmed negative for PEDV, PDCoV, TGEV, and porcine rotaviruses (groups A, 
B, & C) by virus-specific PCRs on rectal swabs and negative for PEDV by a virus-specific indirect 
fluorescent antibody assay.  All pigs were administered an intramuscular injection of Excede® 
(Zoetis) per label instructions.  Pigs were randomized by weight into 7 groups of 6 pigs each, one 
group per room, with the 6 pigs within each group housed together in one room on a solid floor.   
After 3 days acclimation (pigs were 24 days old), pigs in groups 1-7 were orogastrically 
inoculated with 10-3, 10-4, 10-5, 10-6, 10-7, and 10-8 dilutions of the PEDV stock and the virus-
negative cell culture media, respectively, using a size 10 French feeding tube and 60ml syringe 
(10ml/pig) (Table 3.2).  Pigs were evaluated for clinical signs of vomiting, diarrhea, lethargy, and 
body condition daily for the first week, every other day for the second week and then once weekly 
until 28 DPI.  Rectal swabs were collected at 0-7, 10, 14, 21, and 28 DPI.  Serum was collected 
and body weight was recorded on 0, 7, 14, 21, and 28 DPI.  Three of the six pigs in each group 
were randomly selected for necropsy at 7 DPI with the remaining 3 pigs being necropsied at 28 
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DPI.  Sample collections at necropsy and post-mortem diagnostics were identical to those in the 
neonatal pigs study.  In addition, serum samples were tested for PEDV antibody using virus-
specific IFA assay, virus neutralization (VN) test, and a whole virus-based enzyme linked 
immunosorbent assay (ELISA).   
 
Histopathology and immunohistochemistry 
All sections of formalin-fixed jejunum and ileum were microscopically evaluated by a 
veterinary pathologist blinded to individual animal identifications and treatment groups.  Three 
representative villi and crypts with integrated longitudinal sections were randomly selected from 
ileum of each pig for measurement of villus heights and crypt depths using a computerized image 
system following previously described procedures [24].  Villus-height-to-crypt-depth ratio of each 
tissue was calculated as the quotient of the average villus length divided by the average crypt 
depth.   
Serial sections of ileums were evaluated for PEDV antigen by immunohistochemistry (IHC) 
using a PEDV-specific monoclonal antibody (BioNote, Hwaseong-si, Gyeonggi-do, Korea) as 
previously described [24].  The IHC antigen detection was semi-quantitatively scored as 
previously described [26] with the following criteria: 0 = no staining; 1 = approximately 1-10% 
enterocytes with positive staining; 2 = approximately 10%-25% enterocytes with positive staining; 
3 = approximately 25%-50% enterocytes with positive staining; 4 = approximately 50%-100% 
enterocytes with positive staining.  
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Indirect fluorescent antibody (IFA) assay   
Serum samples (N=147) collected at 0, 7, 14, 21, and 28 DPI from the weaned pig study 
were tested for antibodies by the PEDV IFA assay following the previously described procedures 
[24] with modifications.  For IFA plate preparation, confluent Vero cells grown in 96-well plates 
were inoculated with 100 µl/well of the U.S. PEDV prototype strain USA/IA/2013/19338 at 1000 
TCID50/ml and incubated at 37°C, with 5% CO2.  Twenty-four hours later, the inocula were 
removed and cells were fixed with cold 80% acetone for 10 min.  Plates were air dried, sealed and 
stored at -80°C until use.  Serum samples were serially two-fold diluted from 1:40 to 1:5120 in 
PBS, and 100µl of each diluted serum was added to each well of the IFA plates.  After one-hour 
incubation at 37°C, the sera were removed and plates rinsed twice with PBS.  Then 60µl/well of 
1:50 diluted goat anti-swine IgG (γ) antibody conjugated with FITC (Kirkegaard & Perry 
Laboratories, Inc., Gaithersburg, Maryland) was added to each well and incubated at 37°C for 1 h.  
Plates were then rinsed twice with distilled water and cell staining was examined under a 
fluorescent microscope.  A positive signal at a serum dilution of 1:40 or higher was considered to 
be IFA antibody positive. 
 
Virus neutralization (VN) test   
Serum samples (N=147) from the weaned pig study were tested for PEDV neutralizing 
antibodies.  Serum samples were first inactivated at 56°C for 30 min, then 2-fold serially diluted 
from 1:4 to 1:512 dilutions in 96-well plates with a volume of 75µl per well after dilution.  
Subsequently 75µl of 4 × 103 TCID50/ml of PEDV strain USA/IA/2013/19338 was mixed with the 
equal volume of diluted sera and incubated for 1 h at 37°C with 5% CO2.  Then 100µl of the serum-
virus mixture (containing 200 TCID50 of virus) was transferred to 96-well plates with a Vero cell 
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monolayer, and the plates were incubated for 1 h at 37°C.  The cells were washed twice with post-
inoculation media and incubated with 100µl/well of such media for 48 h at 37°C with 5% CO2.  
Then cells were fixed with cold 80% acetone and stained with PEDV N protein-specific 
monoclonal antibody SD6-29 conjugated to FITC (Medgene, Brookings, South Dakota) at a 1:100 
dilution for 40 min.  The staining was examined under a fluorescent microscope.  The reciprocal 
of the highest serum dilution resulting in >90% reduction of staining as compared to the negative 
serum control was defined as the VN titer of the serum sample.  A VN titer of ≥8 was considered 
positive. 
 
Whole virus-based ELISA for PEDV antibody detection 
A U.S. PEDV prototype strain whole virus-based ELISA was developed and validated at the 
ISU VDL for detection of PEDV-specific IgG antibody.  Each batch of one liter of PEDV 
propagated in Vero cells (infectious titers ranging from 105 - 106 TCID50/ml) were subjected to 
one freeze-thaw and then centrifuged at 4,000 × g for 15 min to remove cell debris.  The virus was 
then pelleted by ultracentrifugation at 140,992 × g for 3 h.  The virus pellet was resuspended in 
sterile PBS (1× pH 7.4) at a ratio of 1:100 of the original volume and stored at -80°C until use.  
Polystyrene 96-well microtitration plates (Thermo Fisher Scientific) were coated with the viral 
antigen solution (100μl/well) and incubated at 4°C overnight.  Plates were washed 5 times, blocked 
(300μl/well) with PBS containing 1% bovine serum albumin (Jackson ImmunoResearch Inc., West 
Grove, Pennsylvania), and incubated at 25°C for 2 h.  Plates were then dried at 37°C for 4 h and 
stored at 4°C in a sealed bag with desiccant packs until use.  Serum samples were 1:50 diluted and 
added to the coated plates (100μl/well).  Plates were incubated at 25°C for 1 h and then washed 5 
times with PBS (1× pH 7.4).  Subsequently 100μl of peroxidase-conjugated goat anti-pig IgG (Fc) 
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antibody (Bethyl Laboratories Inc., Montgomery, Texas, USA) at 1:25,000 dilution was added to 
each well and the plates were incubated at 25°C for 1 h.  After a washing step, 100μl of 
tetramethylbenzidine-hydrogen peroxide substrate solution (TMB, Dako North America Inc., 
Carpinteria, California, USA) was added to each well.  The plates were incubated for 5 min at 
room temperature and the reaction was stopped by adding 50μl of stop solution (1 M sulfuric acid) 
to each well.  Reactions were measured as optical density (OD) at 450 nm using an ELISA plate 
reader operated with commercial software (Biotek® Instruments Inc., Winooski, Vermont, USA).  
The antibody response in serum samples was represented as sample-to-positive (S/P) ratios 
calculated as: S/P ratio = (sample OD – blank well control mean OD) / (positive control mean OD 
– blank well control mean OD).  After multiple optimizations, the S/P ratios of >0.8 were 
considered antibody positive, 0.6-0.8 as suspect, and <0.6 as negative [27, 28].   
 
Statistics   
The villus height, crypt depth, and villus/crypt ratio were compared with a generalized linear 
mixed (GLIMMIX) model.  IHC scores were compared using a Kruskal-Wallis Test.  All tests 
were performed using JMP software (SAS Institute, Cary, North Carolina, USA), with P<0.05 
considered significant. 
 
Results 
Infectious titers and PCR results of the 10-fold serially diluted PEDV stock  
A PEDV virus stock (USA/IN/2013/19338 passage 7) with a known infectious titer of 
5.62×105 TCID50/ml was 10-fold serially diluted into virus-negative cell culture medium, giving 
rise to theoretical infectious titers of 5.62×105 to 5.62×10-5 TCID50/ml for the 10
0 to 10-10 dilutions, 
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respectively (Table 3.1).  Infectious titers of each virus dilution were back-titrated in Vero cells by 
end-point titration assay (TCID50/ml) and plaque assay (PFU/ml), with results summarized in 
Table 3.1.  The stock virus and 10-1 to 10-4 dilutions all had the same logarithms of titers as the 
theoretical titers based on the dilution factor, regardless of titration assays in the units of TCID50/ml 
or PFU/ml.  The 10-5 virus dilution had an infectious titer of 5 PFU/ml but remained undetected 
by the end-point titration assay in the unit of TCID50/ml.  The 10
-6 to 10-10 virus dilutions were 
undetected by either the end-point titration assay or the plaque assay during back titration.    
Each virus dilution was also tested in triplicate by a quantitative PEDV N gene-based rRT-
PCR.  The virus stock had an average Ct of 12.2 and the Ct values increased by roughly 3-4 for 
every 10-fold dilution until the 10-7 dilution that had a Ct value of 37.62, beyond which all dilutions 
had Ct>45 (Table 3.1).  This range of Ct values correlated to 2.1×1010 genomic copies/ml in the 
virus stock through 689 genomic copies/ml in the 10-7 dilution, and an undetected number of 
genomic copies/ml in all dilutions beyond that (Table 3.1).   
The PEDV dilutions 10-3 to 10-8, having theoretical infectious titers of 5.62×102 to 5.62×10-
3 TCID50/ml and PCR Ct values of 24.22 to >45, together with virus-negative culture medium 
control, were selected to determine the infection outcomes in 5-day-old piglets and 3-week-old 
pigs (Table 3.2). 
 
Infection outcomes in 5-day-old piglets   
All four 5-day-old piglets in the groups 1 to 5 (inoculated with virus dilutions 10-3 to 10-7) 
and one pig (pig ID 9) in group 6 (inoculated with virus dilution 10-8) developed mild to watery 
diarrhea at 1 DPI and diarrhea lasted through the study period.  Dehydration and lethargy were 
also observed in these piglets at 2 DPI through the end of the study period.  Vomiting was only 
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observed in piglets inoculated with the 10-3 dilution (5.62×102 TCID50/ml, 10ml/pig) at 1 DPI.  
Due to severity of clinical signs, these piglets were euthanized and necropsied at 4 DPI.  In contrast, 
3 pigs (pig IDs 23, 13 and 8) in the group 6 inoculated with virus dilution 10-8 and all 4 pigs in the 
negative control group remained active and clinically unaffected throughout the 7-day study 
period.  
Fecal virus shedding of the inoculated 5-day-old piglets is summarized in Table 3.3 and Fig. 
3.2A.  One pig each in groups 1, 2, and 3 (10-3, 10-4 and 10-5 dilutions) were PCR positive on rectal 
swabs at 1 DPI with Ct values 22.98-39.97.  All 4 pigs in each of groups 1-5 (10-3 – 10-7 dilutions) 
were PCR positive on rectal swabs by 2 DPI and remained positive through the necropsy day 4 
DPI.  One pig (pig ID 9) in group 6 (10-8 dilution) shed virus in rectal swabs starting from 3 DPI 
with a Ct value of 14.2 (Table 3.3).  The quantitative genomic copies/ml of PEDV RNA in rectal 
swabs is shown in Fig. 3.2A.  The average virus shedding in groups 1-5 (10-3 to 10-7 dilutions) at 
2-4 DPI and virus shedding in pig ID 9 from group 6 (10-8 dilution) at 3-4 DPI were similar, having 
107.6 to 109.2 genomic copies/ml.  All rectal swabs from the 3 unaffected pigs (IDs 23, 13 and 8) in 
group 6 (10-8 dilution) and all 4 pigs in the negative control group were negative by PEDV PCR.  
Cecum contents obtained at necropsy were also tested by PEDV PCR and the results were 
consistent with those of the rectal swabs collected on the corresponding necropsy days (data not 
shown). 
Thin-walled small intestine and soft to watery contents in small intestines, ceca and colons 
were observed at necropsy in pigs in groups 1-5 (10-3 – 10-7 dilutions) and one pig (ID 9) of group 
6; similar villous atrophy consistent with viral infection was observed in these pigs.  Villus height 
and crypt depth were measured, villus-height-to-crypt-depth ratios were calculated, and the 
magnitude of IHC staining was scored and compared on ileums of different groups (Table 3.4).  
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Pigs in groups 1-5 (10-3 – 10-7 dilutions) were all necropsied at 4 DPI and there were no significant 
differences between groups in villus height, crypt depth, villus/crypt ratio, or IHC scores.  Only 
one pig (ID 9) from group 6 was necropsied at 4 DPI and was thus not included in the statistical 
analysis.  Microscopic intestinal lesions consistent with viral enteritis were not observed in the 3 
remaining pigs in group 6 and the negative control pigs (group 7); villus height, crypt depth, and 
villus/crypt ratio of ileums of these pigs were not significantly different from each other; IHC 
staining was negative on these pigs.  Compared to the pigs in group 6 (IDs 23, 13 and 8) and group 
7 (negative control), the pigs in groups 1-5 had decreased villus heights, increased crypt depth, 
and lower villus/crypt ratios; however, statistical differences were not analyzed because they were 
necropsied at different DPI.  
 
Infection outcomes in 3-week-old pigs  
In groups 1-3 (10-3 to 10-5 dilutions), 1/6, 1/6, and 6/6 pigs in each group developed mild 
diarrhea at 2, 3, and 4-7 DPI; mild dehydration or lethargy was observed in a few pigs in these 
groups during 3-7 DPI.  No diarrhea, dehydration, or lethargy was observed in pigs in groups 4-7 
(10-6 to 10-8 dilutions and negative control) throughout the duration of the study.  
Fecal virus shedding from the inoculated 3-week-old piglets is summarized in Table 3.5 and 
Fig. 3.2B.  Pigs in all groups were PCR negative on rectal swabs collected before inoculation and 
at 1 DPI.  One pig each in groups 1 and 2 along with two pigs in group 3 were PCR positive on 
rectal swabs by 2 DPI.  All pigs in groups 1-3 were PEDV PCR positive by 4 DPI and remained 
positive through at least 7 DPI although there were variations on PCR Ct values between individual 
pigs.  Most of the remaining pigs in groups 1-3, after necropsy at 7 DPI, continued to shed virus 
in rectal swabs during 10-21 DPI but all pigs in these groups ceased shedding virus at 28 DPI 
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(Table 3.5).  Based on the quantitative genomic copies/ml of PEDV RNA in rectal swabs, the 
average virus shedding in groups 1-3 (10-3 to 10-5 dilutions) had similar patterns: increasing virus 
shedding during 2-6 DPI and decreasing virus shedding after 7 DPI (Fig. 3.2B). However, pigs in 
group 2 (10-4 dilution) had a peak virus shedding during 10-14 DPI (Fig. 3.2B).  All rectal swabs 
from pigs in groups 4-7 (10-6 to 10-8 dilutions and negative control) were negative by PEDV PCR 
through the study period.  Cecum contents obtained at necropsy were also tested by PEDV PCR 
in all pigs and the results were consistent with those of the rectal swabs collected on the 
corresponding necropsy days (data not shown). 
For pigs necropsied at 7 DPI, microscopic lesions consistent with viral infection were 
observed in 2/3 pigs of group 1 (10-3 dilution), 1/3 pigs of group 2 (10-4 dilution), 1/3 pigs of group 
3 (10-5 dilution), and 0/3 pigs of groups 4-7 (10-6 to 10-8 dilutions and negative control); IHC 
staining results were consistent with the presence or absence of microscopic lesions.  However, 
villus heights, crypt depths, villus/crypt ratios of pigs in all groups 1-7 were not significantly 
different from each other at 7 DPI (data not shown).  For pigs necropsied at 28 DPI, no microscopic 
lesions or IHC staining were observed in any pigs of groups 1-7. 
Seroconversion was first observed at 14 DPI for pigs in groups 1-3 (10-3 to 10-5 dilutions) by 
both IFA (Fig. 3.3A) and whole virus-based ELISA (Fig. 3.3C) assays and then remained through 
28 DPI.  PEDV neutralizing antibodies was first detected by VN test at 7 DPI in 1/3 pigs of groups 
1 and 2, and in 2/3 pigs of group 3 (Fig. 3.3B).  Serum anti-PEDV antibody was not detected in 
pigs from groups 4-7 (10-6 to 10-8 dilutions and negative control) throughout the study period by 
any of the 3 antibody assays.   
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Discussion 
One objective of this study was to determine the correlation of PEDV PCR Ct values to the 
infectious titers.  A U.S. PEDV prototype strain cell culture isolate USA/IA/2013/19338 was 10-
fold serially diluted and tested in this study.  Since there are variations among laboratories in 
reporting virus titer units, we determined the infectious titers of the PEDV dilutions using both 
end-point titration assay and plaque assay.  It was found that one TCID50/ml is almost equivalent 
to one PFU/ml for PEDV.  Based on a quantitative PEDV N gene-based rRT-PCR we developed, 
PEDV with an infectious titer of 5 TCID50/ml or 5 PFU/ml had a Ct value of approximate 31 
corresponding to about 4.8×104 genomic copies/ml.  An equation of X = 10(Ct-47.262)/-3.3969, where 
X=genomic copies/ml, was used to transform the Ct values into estimated genomic copies of 
PEDV RNA per ml in samples.  However, these results need to be interpreted with caution.  First, 
a PEDV N gene-based primers and probe and reagents from the Path-ID™ Multiplex One-Step 
RT-PCR Kit (Thermo Fisher Scientific) were used in this study.  PEDV rRT-PCRs using other 
primers, probe, and master mix buffer reagents may generate results somewhat different from what 
we obtained in this study.  Second, correlations of the infectious titers, Ct values and genomic 
copies/ml in this study were obtained using a PEDV cell culture isolate diluted in cell culture 
medium.  For PEDV present in other sample matrices, this correlation could have some variations. 
Another objective of this study was to determine the minimum infectious dose of PEDV in 
5-day-old and 3-week-old naïve conventional pigs.  In 5-day-old pigs, 100% of pigs (4/4 pigs) 
became infected with 10ml of inoculum having titers 560 – 0.056 TCID50/ml (Ct 24.2 – 37.6); 25% 
of pigs (1/4 pigs) became infected with 10ml of inoculum having titer 0.0056 TCID50/ml (Ct>45) 
(Table 3.6).  In 3-week-old pigs, 10ml of inoculum with titers 560 – 5.6 TCID50/ml (Ct 24.2 – 31.4) 
resulted in 100% (6/6 pigs) infection while 10ml of inoculum with titers 0.56 – 0.0056 TCID50/ml 
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(Ct values 35.3 – >45) could not establish infection in any pigs under these study conditions (Table 
3.6).  The smallest virus magnitude that can cause infection in at least one pig in a group is 
considered the minimum infectious dose.  In the 5-day-old pig study, 4 pigs in each group were 
housed separately without direct contact between pigs.  The minimum infectious dose of PEDV 
was 0.056 TCID50 or lower in 5-day-old pigs.  In the 3-week-old pig study, due to space limitation, 
it was not possible to house all pigs individually; however, this did not preclude determination of 
the minimum infectious dose in the current study because the weaned pig groups 4-6 (dilutions 10-
6 to 10-8) had no single pig positive during 28 days study period.  However, if conditions allowed, 
for minimum infectious dose studies, pigs would ideally be housed separately during long-term 
study periods to avoid possible pig-to-pig transmission.  The MID of PEDV was 56 TCID50 in 3-
week-old pigs under our study conditions.  This suggests that the MID for neonatal pigs is at least 
1000-fold lower than it is in weaned pigs.   
Our study confirms that 5-day-old pigs are more susceptible than 3-week-old pigs to PEDV 
infection.  PEDV progresses faster, the fecal virus shedding level is higher, and disease is more 
severe, in 5-day-old pigs than in 3-week-old pigs (Fig 3.2A&B).  We also observed that the 
response among four 5-day-old pigs in each group was comparable as reflected by similar virus 
shedding levels (Table 3.3) and similar microscopic lesions.  In contrast, there was more variation 
in virus shedding among six 3-week-old pigs in each group (Table 3.3).  These observations were 
consistent with previous reports on age-dependent resistance of pigs to TGEV infection [29].  
However, in either 5-day-old or 3-week-old pig models, once pigs were infected and virus 
replication began, the initial dose of virus appears to have little impact at the group level on the 
average amount of fecal viral shedding, average severity of microscopic lesions/IHC staining, or 
the average magnitude of antibody titer that is subsequently developed.  It should be noted that the 
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5-day-old piglets in this study were fed a mixture of liquid milk replacer and yogurt, which were 
possibly devoid of IgG, IgA and other immunologic ingredients found in sow milk.  Thus, the 
piglets raised under the current study conditions could be more susceptible to PEDV infection than 
piglets at the corresponding ages that were naturally nursed by sows under field conditions.  
Previous studies also demonstrated that PEDV infection induces greater disease severity in 
neonatal piglets than in weaned pigs although the minimum infectious dose of PEDV was not 
determined in those studies [24, 30-32].  The exact reasons for the greater severity of PED in 
neonatal piglets are unknown but there may be several contributing factors including: 1)  an 
immature immune system   [33, 34]; for example, the level of natural IFN-α production by porcine 
blood mononuclear cells is lower in neonates and the phagocytic cells present in newborn piglets 
generally have reduced phagocytic activity as compared with adult animals [35, 36]; 2) neonatal 
piglets are more vulnerable to electrolyte/fluid imbalance and dehydration [33]; 3) the intestinal 
villi of neonatal piglets are longer and may have more mature permissive enterocytes than weaned 
pigs [37]; 4) and a  slower replacement rate of villous enterocytes (7-10 days) in neonatal pigs 
compared to 2-4 days in weaned pigs [38].  The virus mainly infects and destroys mature 
enterocytes lining the villi of small intestine, resulting in shortening and blunting of villi.  But the 
intestinal crypt epithelial cells basically remain uninfected and serve to replace the destroyed 
villous enterocytes.  Regeneration of villous enterocytes in neonatal piglets is not as rapid as that 
in weaned pigs; this may explain why villous atrophy is more severe in neonatal than in weaned 
pigs.  Recently Jung et al [31, 39] further demonstrated that neonatal pigs have low numbers of 
LGR5+ (marker for crypt stem cell) cells and low levels of Ki67 staining (marker for crypt 
proliferation) in contrast to large numbers of LGR5+ cells in the crypts and high proliferation of 
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intestinal crypt cells in weaned pigs, explaining the rapid turnover or recovery rate of villous 
enterocytes in weaned pigs.  
Success rate of PEDV isolation in cell culture has been low.  Currently swine bioassay has 
remained the most reliable means to determine if infectious PEDV is present in a sample.  Data 
from this study suggests a neonatal pig bioassay is more sensitive than a weaned pig bioassay to 
assess PEDV infectivity.  Regarding duration of the swine bioassay, we observed that one pig (ID 
9) in group 6 of the 5-day-old pig study did not shed virus in rectal swabs until 3 DPI; thus 2-day 
duration of pig bioassay may not be sufficient to evaluate the infection outcome.  We propose that 
7-day duration would be considered appropriate for PEDV swine bioassay. 
In summary, using a U.S. PEDV prototype isolate diluted in culture medium, we 
determined the correlations of PEDV infectious titers to PCR Ct values and genomic copies per 
ml.  We further demonstrated that PEDV infectious dose is age-dependent with a significantly 
lower MID for neonatal pigs than for weaned pigs. This information should be taken into 
consideration when interpreting clinical relevance of PEDV PCR results and when designing a 
PEDV bioassay model. The observation of such a low MID in neonates also emphasizes the 
importance of strict biosecurity and thorough cleaning/disinfection on sow farms.  In this study, 
the effect of PEDV infectious doses on infection outcomes was evaluated in naïve conventional 
neonatal and weaned pigs.  It must be noted that infectious dose effects in previously exposed or 
vaccinated pigs may be different from naïve pigs.  In addition, a U.S. PEDV prototype cell 
culture isolate was used in this study and it remains to be determined whether or not U.S. PEDV 
S-INDEL-variant isolate has similar minimum infectious dose and pathogenicity. 
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Figures 
 
Fig. 3.1. Elevated tubs used to house 5-day-old piglets in this study.  One tub was located in each 
room. Each tub was split into 4 compartments with one pig per compartment.  Design of the tub 
prevented contact between pigs and movement of feces or other waste between tub 
compartments. 
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Fig 3.2. Virus shedding in rectal swabs of the 5-day-old pig study (A) and of the 3-week-old pig 
study (B) as determined by a quantitative PEDV N gene-based rRT-PCR.  The virus titers 
(Log10Genomic copies/ml) at each time points were mean virus titers of all available pigs (both 
PCR positive and negative pigs) except the 10-8 group in the 5-day-old pig study where only one 
out of 4 pigs was positive in the study period and included in figure (A). 
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Fig 3.3. Serum antibody responses in 3-week-old pigs inoculated with serial dilutions of PEDV.  
IFA antibody titers (A), serum virus neutralizing antibody titers (B), and PEDV whole virus-
based ELISA antibody titers (C) were shown for 3 pigs in each group that went through 28 days 
post inoculation.   
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Table 3.1. Infectious titers, PCR Ct values and genomic copies/ml of serial dilutions of PEDV 
stock 
Dilution of 
stock virus 
TCID50/ml 
(Theoretical) 
TCID50/ml          
(Back titrated) 
PFU/ml              
(Back 
titrated) 
Ct* 
Genomic 
Copies/ml* 
Stock Virus 562,000 562,000 680,000 12.2 2.10E+10 
 10-1 56,200 31,600 49,000 16.76 9.54E+08 
 10-2 5,620 5,620 6,600 20.21 9.20E+07 
 10-3 562 316 430 24.22 6.07E+06 
 10-4 56.2 56.2 23 28.22 4.03E+05 
 10-5 5.62 0 5 31.37 4.77E+04 
 10-6 0.562 0 0 35.28 3.37E+03 
 10-7 0.0562 0 0 37.62 6.89E+02 
 10-8 0.00562 0 0 >45 0 
 10-9 0.000562 0 0 >45 0 
 10-10 0.0000562 0 0 >45 0 
Neg Ctl 0 0 0 >45 0 
* Average values of triplicate PCR reactions for each dilution.   
 
 
 
Table 3.2. Experimental Design of the neonatal and weaned pig studies 
Virus Dilution 
Used for 
Inoculation 
Inoculum 
Volume 
  Neonatal pig study   Weaned pig study 
  
Group  Pigs 
  
Group Pigs 
Necropsy  
7 DPI 
Necropsy  
28 DPI 
 10-3 10 ml  1 N=4  1 N=6 N=3 N=3 
 10-4 10 ml  2 N=4  2 N=6 N=3 N=3 
 10-5 10 ml  3 N=4  3 N=6 N=3 N=3 
 10-6 10 ml  4 N=4  4 N=6 N=3 N=3 
 10-7 10 ml  5 N=4  5 N=6 N=3 N=3 
 10-8 10 ml  6 N=4  6 N=6 N=3 N=3 
Neg Ctl 10 ml   7 N=4   7 N=6 N=3 N=3 
 
 
 
 
 
Table 3.3. PEDV shedding in rectal swabs of the neonatal piglets* 
Group 
Inocula (10ml/pig) 
Pig ID 
PEDV rRT-PCR Ct values 
Dilution TCID50/ml Ct 0 DPI  1 DPI  2 DPI  3 DPI  4 DPI  5 DPI  6 DPI  7 DPI  
1  10-3 562 24.22 
10 >45 >45 28.63 19.3 29.6 X X X 
32 >45 >45 17.15 15.61 21.33 X X X 
15 >45 22.98 17.83 19.29 17.06 X X X 
6 >45 >45 17.03 15.62 14.65 X X X 
2  10-4 56.2 28.22 
27 >45 >45 15.44 9.96 13.06 X X X 
7 >45 >45 27.75 25.58 19.41 X X X 
29 >45 39.97 22.24 24.6 17.43 X X X 
28 >45 >45 20.64 21.05 30.57 X X X 
3  10-5 5.62 31.37 
16 >45 >45 22.15 19.58 15.87 X X X 
3 >45 >45 21.71 21.76 18.08 X X X 
5 >45 >45 20.05 19.31 16.46 X X X 
4 >45 33.33 19.54 22.67 17.22 X X X 
4  10-6 0.562 35.28 
20 >45 >45 20.19 24.36 15.03 X X X 
18 >45 >45 12.28 14.38 15.24 X X X 
26 >45 >45 21.86 21.56 17.74 X X X 
17 >45 >45 20.12 17.27 14.81 X X X 
5  10-7 0.0562 37.62 
12 >45 >45 21.55 21.24 24.69 X X X 
25 >45 >45 18.95 24.61 22.31 X X X 
14 >45 >45 21.12 20.07 23.61 X X X 
2 >45 >45 20.15 16.87 13.73 X X X 
6  10-8 0.00562 >45 
9 >45 >45 >45 14.2 19.66 X X X 
23 >45 >45 >45 >45 >45 >45 >45 >45 
13 >45 >45 >45 >45 >45 >45 >45 >45 
8 >45 >45 >45 >45 >45 >45 >45 >45 
7 Neg Ctl 0 >45 
21 >45 >45 >45 >45 >45 >45 >45 >45 
24 >45 >45 >45 >45 >45 >45 >45 >45 
1 >45 >45 >45 >45 >45 >45 >45 >45 
31 >45 >45 >45 >45 >45 >45 >45 >45 
*All pigs PCR positive on rectal swabs were necropsied on day 4 due to the severity of clinical signs 
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Table 3.4. Mean villus height (µm), crypt depth (µm), villus/crypt ratio, and IHC scores in ileums of the neonatal piglets  
  
Group  Dilution Pigs 
Villous Height    Crypt Depth   Villus/Crypt ratio   IHC Score 
Mean ± SEM   Mean ± SEM   Mean ± SEM   Mean ± SEM 
Necropsy 
at 4 DPI 
1  10-3 N=4 218.13 ± 16.33  161.64 ± 6.81  1.35 ± 0.10  2.94 ± 0.68 
2  10-4 N=4 208.56 ± 39.94  171.22 ± 6.59  1.21 ± 0.21  3.81 ± 0.19 
3  10-5 N=4 272.19 ± 22.03  162.21 ± 9.71  1.67 ± 0.04  3.88 ± 0.13 
4  10-6 N=4 230.85 ± 19.33  152.46 ± 4.52  1.51 ± 0.12  3.63 ± 0.24 
5  10-7 N=4 228.18 ± 33.57  158.24 ± 10.89  1.45 ± 0.21  3.94 ± 0.06 
6*  10-8 N=1 222.49   143.12   1.55   4.00 
Necropsy 
at 7 DPI 
6  10-8 N=3 423.17 ± 51.35  118.60 ± 16.81  3.81 ± 0.87  0.00 ± .000 
7 Neg Ctl N=4 450.76 ± 20.05   108.40 ± 12.61   4.31 ± 0.46   0.00 ± 0.00 
* Mean and standard error of the mean (SEM) could not be calculated nor could statistical comparison be performed on the 
one pig from Group 6 necropsied at 4 DPI. 
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Table 3.5. PEDV shedding in rectal swabs of the weaned pigs*  
Group 
Inocula (10ml/pig) 
Pig ID 
PEDV rRT-PCR Ct values 
Dilution TCID50/ml Ct 
0 
DPI  
1 
DPI  
2 DPI  3 DPI  4 DPI  5 DPI  6 DPI  7 DPI  
10 
DPI 
14 
DPI 
21 
DPI 
28 
DPI 
1  10-3 562 24.22 
7 >45 >45 >45 34.88 34.87 29.42 31.10 32.94 33.30 >45 >45 >45 
66 >45 >45 >45 32.09 19.24 19.72 15.62 19.17 34.60 35.21 36.71 >45 
89 >45 >45 24.00 16.66 20.13 15.04 20.08 22.26 35.33 37.94 >45 >45 
3 >45 >45 >45 35.01 34.60 29.67 30.79 24.69 X X X X 
10 >45 >45 >45 27.50 24.34 20.99 19.13 26.88 X X X X 
86 >45 >45 >45 29.64 29.63 16.71 16.14 17.97 X X X X 
2  10-4 56.2 28.22 
18 >45 >45 >45 32.68 34.18 30.13 32.26 35.07 24.21 14.46 34.12 >45 
64 >45 >45 >45 33.44 33.92 31.83 32.25 30.72 15.70 29.83 36.08 >45 
96 >45 >45 31.05 17.61 16.78 14.52 13.78 30.43 37.68 27.13 35.69 >45 
77 >45 >45 >45 33.35 31.69 32.18 31.73 38.46 X X X X 
83 >45 >45 >45 32.14 33.61 32.19 28.42 34.73 X X X X 
93 >45 >45 >45 33.13 31.81 32.29 33.07 36.02 X X X X 
3  10-5 5.62 31.37 
12 >45 >45 >45 >45 34.16 28.73 30.51 21.96 28.21 30.87 37.67 >45 
74 >45 >45 33.07 19.19 19.22 17.96 17.29 32.14 >45 35.71 >45 >45 
90 >45 >45 36.53 32.05 19.58 15.30 16.47 17.87 34.13 33.42 >45 >45 
2 >45 >45 >45 37.58 33.87 31.46 42.98 35.07 X X X X 
78 >45 >45 >45 34.72 19.07 19.75 13.03 21.25 X X X X 
99 >45 >45 >45 >45 33.23 29.56 23.39 22.69 X X X X 
4ǂ  10-6 0.562 35.28 
6; 68; 81 >45 >45 >45 >45 >45 >45 >45 >45 >45 >45 >45 >45 
9; 14; 91 >45 >45 >45 >45 >45 >45 >45 >45 X X X X 
5ǂ  10-7 0.0562 37.62 
15; 20; 67 >45 >45 >45 >45 >45 >45 >45 >45 >45 >45 >45 >45 
11; 16; 98 >45 >45 >45 >45 >45 >45 >45 >45 X X X X 
6ǂ  10-8 0.00562 >45 
4; 21; 87 >45 >45 >45 >45 >45 >45 >45 >45 >45 >45 >45 >45 
8; 73; 79 >45 >45 >45 >45 >45 >45 >45 >45 X X X X 
7ǂ Neg Ctl 0 >45 
70; 76; 92 >45 >45 >45 >45 >45 >45 >45 >45 >45 >45 >45 >45 
17; 72; 88 >45 >45 >45 >45 >45 >45 >45 >45 X X X X 
* 3 pigs were necropsied at 7 DPI with the remaining 3 being necropsied at 28 DPI       
ǂ For groups 4, 5, 6, and 7, rectal swabs from all pigs were negative by PEDV rRT-PCR. To save space, 3 pigs are shown in one row. 
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Table 3.6.  Summary of PEDV infection outcomes in neonatal and weaned pigs 
Group 
Inocula (10ml/pig)  Infection Outcomes 
Dilution TCID50/ml Ct   
Neonatal Piglets 
(5-day-old) 
Weaned Pigs           
(21-day-old) 
1  10-3 562 24.22  100% (4/4) 100% (6/6) 
2  10-4 56.2 28.22  100% (4/4) 100% (6/6) 
3  10-5 5.62 31.37  100% (4/4) 100% (6/6) 
4  10-6 0.562 35.28  100% (4/4) 0 (0/6) 
5  10-7 0.0562 37.62  100% (4/4) 0 (0/6) 
6  10-8 0.00562 >45  25% (1/4) 0 (0/6) 
7 Neg Ctl 0 >45   0 (0/4) 0 (0/6) 
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CHAPTER 4: GENERAL CONCLUSIONS 
PEDV has been an economically devastating disease in Europe and Asia since it was first 
identified back in 1971.  In its first year in the US it resulted in the death of over 7 million pigs 
not to mention economic losses incurred by disruptions in pig flow/production. 
Our research along with the literature review conducted for this thesis yielded a great deal 
of useful information.  More importantly, it underscores areas where our knowledge regarding 
PEDV is lacking.  Innate, humoral, and cell mediated immune responses to PEDV have been 
partially characterized.  Maternal and mucosal immunity are vital to protection of neonatal pigs, 
the most susceptible group of pigs.  Further characterization of the sow’s immune response and 
how it translates to protective antibody titers in both colostrum and milk is needed.  Two 
conditionally licensed vaccines are available in the US; one based on a killed virus, and the other 
on a replication deficient virus particle. Both vaccines have some issues with efficacy in naïve 
swine populations.  Modified live virus vaccines may serve as more effective vaccine platform 
and should be actively pursued.  The specific route of entry for PEDV into North America has 
not been definitively identified.  Until this route(s) is/are identified, steps cannot be taken to 
close the holes in our nation’s biosecurity.  We therefore remain susceptible to the introduction 
of more exotic diseases.  
Specifically, the research work performed in this thesis was to determine the correlation 
of PEDV infectious titers to the real-time RT-PCR Ct values and to determine the minimum 
infectious dose of PEDV in naïve conventional neonatal and weaned pigs.  
We first demonstrated that the end-point titration assay yields similar PEDV titer 
(TCID50/ml) to the plaque assay (PFU/ml).  Five TCID50/ml (or 5 PFU/ml) roughly correlates to 
a Ct value of 31 and 4.8×104 genomic copies/ml.  However, it is important to note that these 
correlations are based on a PEDV cell culture isolate diluted in cell culture medium and RT-PCR 
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conditions described in this thesis.  When RT-PCR conditions and sample matrix are different, 
the correlation described above could differ as well.  We also determined that a 10 ml inoculum 
with a titer of 0.056 TCID50/ml and a Ct of 37.62 was able to infect 4/4 (100%) of 5-day-old 
pigs, and a 10 ml inoculum with a titer of 0.0056 TCID50/ml and a Ct >45 was able to infect ¼ 
(25%) of 5-day-old pigs.  Unfortunately, no further viral dilutions were used in this study, so a 
true MID was not determined for 5-day-old pigs.  For 3-week-old pigs we determined that a 10 
ml of inoculum with a titer of 5.6 TCID50/ml and a Ct of 31.4 was able to infect 6/6 (100%) pigs, 
and that no further dilutions were able to infect a single pig.  This shows at least a 1000-fold 
difference in MID for 5-day-old pigs compared to 3-week-old pigs, which confirms the greater 
susceptibility/increased disease severity in neonatal pigs as demonstrated in previous studies.  
Factors contributing to this difference, as described in Chapter 3 of this thesis, include: 1) an 
immature immune system, 2) increased vulnerability to electrolyte/fluid imbalance and 
dehydration, 3) an increased number of permissible enterocytes, and 4) a slower replacement of 
enterocytes in neonatal piglets.  We also showed that an IgG titer was detectable by both IFA and 
whole virus ELISA in the serum of 3-week-old pigs by 14 DPI, and a virus neutralizing titer was 
detectable as early as 7 DPI.  One possible explanation for this difference is the presence of 
neutralizing IgM isotype antibodies prior to the formation of IgG antibodies.  Interestingly, we 
also showed that the extent of fecal viral shedding, severity of histopathologic lesions, and the 
magnitude of antibody titer subsequently developed were not affected by the initial dose of virus 
administered to pigs once a PEDV infection was established. 
This research produced some clear take away points for the swine industry that should 
have real utility in the field.  It showed that PEDV is infectious in an age dependent manner with 
a significantly lower MID for neonatal pigs than weaned pigs.  It also showed that the MID for 
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neonatal pigs is below the threshold of detection by our PEDV N gene-based real-time RT-PCR.  
As such it demonstrated that a neonatal bioassay model would be significantly more sensitive 
than a weaned pig bioassay model, and would likely be more sensitive than an RT-PCR.  Most 
important of all, the results of this study underline the importance of strict biosecurity and 
thorough cleaning/disinfection on all farms but especially sow farms where neonatal pigs are 
present. 
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